Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-31

Clinical Trial Update: Efficacy and Toxicity of Total Neoadjuvant Sandwich Treatment Via Short Course Radiotherapy in the Treatment of Stage II and III Rectal Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating total neoadjuvant sandwich treatment via short-course radiotherapy for stage II/III rectal cancer. The study is currently recruiting …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ain Shams University | Conditions: Rectal Cancer | Phase 2 | Status: RECRUITING